ROIV
USDRoivant Sciences Ltd. Common Shares
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$19.550
Максимум
$19.890
Минимум
$19.315
Объем
9.01M
Фундаментальные показатели компании
Рыночная капитализация
13.6B
Отрасль
Биотехнология
Страна
United Kingdom
Статистические данные торговли
Средний объем
7.66M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.